Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model.

Liu T, Huang Y, Zhang J, Qin W, Chi H, Chen J, Yu Z, Chen C.

Stem Cells Dev. 2014 Jul 1;23(13):1548-57. doi: 10.1089/scd.2013.0371. Epub 2014 Apr 25.

3.

Transplantation of ovarian granulosa‑like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure.

Liu T, Li Q, Wang S, Chen C, Zheng J.

Mol Med Rep. 2016 Jun;13(6):5053-8. doi: 10.3892/mmr.2016.5191. Epub 2016 Apr 26.

4.
5.

Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.

Leng L, Tan Y, Gong F, Hu L, Ouyang Q, Zhao Y, Lu G, Lin G.

Hum Reprod. 2015 Mar;30(3):737-48. doi: 10.1093/humrep/deu358. Epub 2015 Jan 12.

PMID:
25586786
6.
7.

Differentiation of rat iPS cells and ES cells into granulosa cell-like cells in vitro.

Zhang J, Li H, Wu Z, Tan X, Liu F, Huang X, Fang X.

Acta Biochim Biophys Sin (Shanghai). 2013 Apr;45(4):289-95. doi: 10.1093/abbs/gmt008. Epub 2013 Feb 11.

PMID:
23403512
8.

Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells.

Hillier SG, Anderson RA, Williams AR, Tetsuka M.

Mol Hum Reprod. 1998 Aug;4(8):811-5.

PMID:
9733440
9.

Differentiation of mouse induced pluripotent stem cells into corneal epithelial-like cells.

Yu D, Chen M, Sun X, Ge J.

Cell Biol Int. 2013 Jan;37(1):87-94. doi: 10.1002/cbin.10007. Epub 2012 Dec 4.

PMID:
23339091
10.

An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium.

Ong A, Maines-Bandiera SL, Roskelley CD, Auersperg N.

Int J Cancer. 2000 Feb 1;85(3):430-7.

11.

Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice.

Wang Z, Wang Y, Yang T, Li J, Yang X.

Stem Cell Res Ther. 2017 Jan 23;8(1):11. doi: 10.1186/s13287-016-0458-1. Erratum in: Stem Cell Res Ther. 2017 Mar 8;8(1):49.

13.

MicroRNA-22-3p is down-regulated in the plasma of Han Chinese patients with premature ovarian failure.

Dang Y, Zhao S, Qin Y, Han T, Li W, Chen ZJ.

Fertil Steril. 2015 Mar;103(3):802-7.e1. doi: 10.1016/j.fertnstert.2014.12.106. Epub 2015 Jan 10.

PMID:
25585503
14.

Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells.

Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC.

Endocrinology. 2001 Jun;142(6):2351-60.

PMID:
11356682
15.

Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer.

Parrott JA, Kim G, Mosher R, Skinner MK.

Mol Cell Endocrinol. 2000 Sep 25;167(1-2):77-87.

PMID:
11000522
16.
17.

Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium.

Hayashi R, Ishikawa Y, Ito M, Kageyama T, Takashiba K, Fujioka T, Tsujikawa M, Miyoshi H, Yamato M, Nakamura Y, Nishida K.

PLoS One. 2012;7(9):e45435. doi: 10.1371/journal.pone.0045435. Epub 2012 Sep 24.

18.

Telocytes as potential targets in a cyclophosphamide-induced animal model of premature ovarian failure.

Liu T, Wang S, Li Q, Huang Y, Chen C, Zheng J.

Mol Med Rep. 2016 Sep;14(3):2415-22. doi: 10.3892/mmr.2016.5540. Epub 2016 Jul 22.

19.

E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.

Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6249-54.

20.

Supplemental Content

Support Center